Salene M W Jones1, Jean C Yi1, Heather S L Jim2, Alison W Loren3, Navneet S Majhail4, Joseph Uberti5, Victoria Whalen6, Wendy M Leisenring1, Mary E D Flowers1,7, Stephanie J Lee1,7, Karen L Syrjala8,9. 1. Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 2. Moffitt Cancer Center, Tampa, FL, USA. 3. University of Pennsylvania, Philadelphia, PA, USA. 4. Cleveland Clinic, Cleveland, OH, USA. 5. Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA. 6. University of Nebraska, Omaha, NB, USA. 7. University of Washington School of Medicine, 1100 Fairview Ave N, D5-220, Seattle, WA, 98109, USA. 8. Fred Hutchinson Cancer Research Center, Seattle, WA, USA. ksyrjala@fredhutch.org. 9. University of Washington School of Medicine, 1100 Fairview Ave N, D5-220, Seattle, WA, 98109, USA. ksyrjala@fredhutch.org.
Abstract
PURPOSE: Cancer has long-term financial consequences. Adolescent and young adult (AYA) and middle-aged cancer survivors may experience more financial toxicity than older adults. This study examined age differences in financial distress in hematopoietic cell transplant survivors and whether these differences result from measurement bias, more financial barriers to care, or an overall higher level of distress. METHODS: Hematologic malignancy survivors (n = 1135, 2-10 years post-transplant) completed the Cancer and Treatment Distress Scale (CTXD) and demographics as part of the baseline assessment for a randomized clinical trial. The CTXD has seven subscales, but for this study, we examined the financial distress subscale and the overall score. Item response theory analyses tested for bias by age and gender. Multivariate linear regression tested the association of age and gender with the CTXD scores while controlling for financial barriers to care. RESULTS: No bias was found on the CTXD. AYA (p < 0.01) and middle-aged adults (p < 0.001) reported more financial and overall distress than older (age 65+) adults. The same association of age and financial distress was observed in women (p < 0.01). However, only middle-aged men (p < 0.01) reported more financial and overall distress than older men; AYA men did not (p > 0.18). Financial barriers to care were not associated with financial or overall distress. CONCLUSIONS: Part of the increase in financial distress with younger age may be due to a higher risk of general distress. Policy initiatives to control cancer costs should consider life stage and the unique financial challenges at different ages for men and women.
PURPOSE:Cancer has long-term financial consequences. Adolescent and young adult (AYA) and middle-aged cancer survivors may experience more financial toxicity than older adults. This study examined age differences in financial distress in hematopoietic cell transplant survivors and whether these differences result from measurement bias, more financial barriers to care, or an overall higher level of distress. METHODS:Hematologic malignancy survivors (n = 1135, 2-10 years post-transplant) completed the Cancer and Treatment Distress Scale (CTXD) and demographics as part of the baseline assessment for a randomized clinical trial. The CTXD has seven subscales, but for this study, we examined the financial distress subscale and the overall score. Item response theory analyses tested for bias by age and gender. Multivariate linear regression tested the association of age and gender with the CTXD scores while controlling for financial barriers to care. RESULTS: No bias was found on the CTXD. AYA (p < 0.01) and middle-aged adults (p < 0.001) reported more financial and overall distress than older (age 65+) adults. The same association of age and financial distress was observed in women (p < 0.01). However, only middle-aged men (p < 0.01) reported more financial and overall distress than older men; AYA men did not (p > 0.18). Financial barriers to care were not associated with financial or overall distress. CONCLUSIONS: Part of the increase in financial distress with younger age may be due to a higher risk of general distress. Policy initiatives to control cancer costs should consider life stage and the unique financial challenges at different ages for men and women.
Authors: Christopher S Lathan; Angel Cronin; Reginald Tucker-Seeley; S Yousuf Zafar; John Z Ayanian; Deborah Schrag Journal: J Clin Oncol Date: 2016-02-29 Impact factor: 44.544
Authors: A Tichelli; S Gerull; A Holbro; A Buser; G Nair; M Medinger; D Heim; J P Halter; J R Passweg Journal: Bone Marrow Transplant Date: 2017-06-26 Impact factor: 5.483
Authors: Karen L Syrjala; Marie-Laure Crouch; Wendy M Leisenring; Mary E D Flowers; Samantha B Artherholt; Allison Stover Fiscalini; Eleni Romano; Joan M Romano; Paul J Martin; Jean C Yi Journal: Biol Blood Marrow Transplant Date: 2018-05-09 Impact factor: 5.742
Authors: Jennifer M Knight; Karen L Syrjala; Navneet S Majhail; Michael Martens; Jennifer Le-Rademacher; Brent R Logan; Stephanie J Lee; Paul B Jacobsen; William A Wood; Heather S L Jim; John R Wingard; Mary M Horowitz; Muneer H Abidi; Mingwei Fei; Laura Rawls; J Douglas Rizzo Journal: Biol Blood Marrow Transplant Date: 2016-08-23 Impact factor: 5.742
Authors: Kristina Geue; Annekathrin Sender; Ricarda Schmidt; Diana Richter; Andreas Hinz; Thomas Schulte; Elmar Brähler; Yve Stöbel-Richter Journal: Qual Life Res Date: 2013-11-07 Impact factor: 4.147
Authors: Giselle K Perez; John M Salsman; Kaitlyn Fladeboe; Anne C Kirchhoff; Elyse R Park; Abby R Rosenberg Journal: Am Soc Clin Oncol Educ Book Date: 2020-03
Authors: Irina B Grafova; Sharon L Manne; Elisa V Bandera; Biren Saraiya; Adana A M Llanos; Katie A Devine; Shawna V Hudson; Lisa E Paddock; Jennifer Tsui; Jennifer Elliott; Antoinette M Stroup; Paul R Duberstein Journal: Support Care Cancer Date: 2021-05-04 Impact factor: 3.603
Authors: Seth J Rotz; Jean C Yi; Betty K Hamilton; Wei Wei; Jaime M Preussler; Jan Cerny; Abhinav Deol; Heather Jim; Nandita Khera; Theresa Hahn; Shahrukh K Hashmi; Shernan Holtan; Samantha M Jaglowski; Alison W Loren; Joseph McGuirk; Jana Reynolds; Wael Saber; Bipin N Savani; Patrick Stiff; Joseph Uberti; John R Wingard; William A Wood; K Scott Baker; Navneet S Majhail; Karen L Syrjala Journal: Transplant Cell Ther Date: 2022-07-22
Authors: Elizabeth S Ver Hoeve; Leila Ali-Akbarian; Sarah N Price; Nurhyikmah M Lothfi; Heidi A Hamann Journal: Support Care Cancer Date: 2020-05-03 Impact factor: 3.359
Authors: Rahul Banerjee; Jean C Yi; Navneet S Majhail; Heather S L Jim; Joseph Uberti; Victoria Whalen; Alison W Loren; Karen L Syrjala Journal: Biol Blood Marrow Transplant Date: 2020-08-08 Impact factor: 5.742